Institutional Ownership
Q32 Bio Inc
CUSIP 746964105COMQTTBQ1 2026
Institutional Holders
50
13F filers
Shares Held
9.07M
Aggregate institutional
Institutional Value
$56.99M
Q1 2026
Net New Holders
+0
8 new · 8 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions8
Increased14
Decreased9
Sold out8
Institutional Holders
50 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Orbimed Advisors LLC | 2.25M | $14.46M | 0 | Held |
| 2 | Atlas Venture Life Science Advisors, LLC | 2.09M | $13.43M | 0 | Held |
| 3 | Opaleye Management Inc. | 1.26M | $8.06M | +1.04M | Added |
| 4 | Carlyle Group Inc. | 1.10M | $7.08M | 0 | Held |
| 5 | Arch Venture Management, LLC | 320.5K | $2.06M | 0 | Held |
| 6 | Acorn Capital Advisors, LLC | 315.1K | $2.02M | −178.4K | Reduced |
| 7 | Mackenzie Financial Corp | 246.3K | $1.58M | +246.3K | New |
| 8 | Sanofi | 244.1K | $1.57M | 0 | Held |
| 9 | Renaissance Technologies LLC | 206.9K | $1.33M | +107.3K | Added |
| 10 | Monimus Capital Management, LP | 134.3K | $862.3K | +134.3K | New |
40 more institutional holders on Premium
See every fund holding Q32 Bio Inc, with full quarter-over-quarter share changes.
Unlock all holders